Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MGI Pharma and MethylGene to collaborate on DNA MeTase inhibitor development

Aug. 16, 2000

New farnesyl protein transferase inhibitors useful for various tumors

Aug. 11, 2000

Theratechnologies to begin PDT trial in Canada

Aug. 11, 2000

EPTTCO and Onyx establish agreement for anticancer agents

Aug. 11, 2000

New compounds from Novartis useful for proliferative diseases

Aug. 10, 2000

Licensing opportunity from NIH: copper complexes

Aug. 10, 2000

New polypeptides useful for treatment of metastases

Aug. 9, 2000

New antiangiogenic agents under development at Merck KGaA

Aug. 9, 2000

Novel growth factor receptor inhibitors described by Sugen

Aug. 9, 2000

Genasense receives orphan drug status for treatment of malignant melanoma

Aug. 9, 2000

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...